» Articles » PMID: 38463630

Interactions Between Ras and Rap Signaling Pathways During Neurodevelopment in Health and Disease

Overview
Specialty Molecular Biology
Date 2024 Mar 11
PMID 38463630
Authors
Affiliations
Soon will be listed here.
Abstract

The Ras family of small GTPases coordinates tissue development by modulating cell proliferation, cell-cell adhesion, and cellular morphology. Perturbations of any of these key steps alter nervous system development and are associated with neurological disorders. While the underlying causes are not known, genetic mutations in Ras and Rap GTPase signaling pathways have been identified in numerous neurodevelopmental disorders, including autism spectrum, neurofibromatosis, intellectual disability, epilepsy, and schizophrenia. Despite diverse clinical presentations, intersections between these two signaling pathways may provide a better understanding of how deviations in neurodevelopment give rise to neurological disorders. In this review, we focus on presynaptic and postsynaptic functions of Ras and Rap GTPases. We highlight various roles of these small GTPases during synapse formation and plasticity. Based on genomic analyses, we discuss how disease-related mutations in Ras and Rap signaling proteins may underlie human disorders. Finally, we discuss how recent observations have identified molecular interactions between these pathways and how these findings may provide insights into the mechanisms that underlie neurodevelopmental disorders.

Citing Articles

CellFIE: Integrating Pathway Discovery With Pooled Profiling of Perturbations Uncovers Pathways of Huntington's Disease, Including Genetic Modifiers of Neuronal Development and Morphology.

Kang B, Murphy M, Ng C, Leventhal M, Huynh N, Im E bioRxiv. 2025; .

PMID: 40027702 PMC: 11870572. DOI: 10.1101/2025.02.19.639023.

References
1.
The I, Hannigan G, Cowley G, Reginald S, Zhong Y, Gusella J . Rescue of a Drosophila NF1 mutant phenotype by protein kinase A. Science. 1997; 276(5313):791-4. DOI: 10.1126/science.276.5313.791. View

2.
Hamdan F, Daoud H, Piton A, Gauthier J, Dobrzeniecka S, Krebs M . De novo SYNGAP1 mutations in nonsyndromic intellectual disability and autism. Biol Psychiatry. 2011; 69(9):898-901. DOI: 10.1016/j.biopsych.2010.11.015. View

3.
Gamache T, Araki Y, Huganir R . Twenty Years of SynGAP Research: From Synapses to Cognition. J Neurosci. 2020; 40(8):1596-1605. PMC: 7046327. DOI: 10.1523/JNEUROSCI.0420-19.2020. View

4.
Cirstea I, Kutsche K, Dvorsky R, Gremer L, Carta C, Horn D . A restricted spectrum of NRAS mutations causes Noonan syndrome. Nat Genet. 2009; 42(1):27-9. PMC: 3118669. DOI: 10.1038/ng.497. View

5.
Diggs-Andrews K, Gutmann D . Modeling cognitive dysfunction in neurofibromatosis-1. Trends Neurosci. 2013; 36(4):237-47. PMC: 3622809. DOI: 10.1016/j.tins.2012.12.002. View